Gesamtlänge aller Episoden: 109 days 7 hours 30 minutes
Dr. Tesha Monteith talks with Dr. Stephanie Nahas about commonly missed and lesser-known primary headache disorders. Disclosures can be found at Neurology.org
Dr. Halley Alexander talks with Dr. David Greer about updating and clarifying the brain death/death by neurologic criteria guidelines for adult and pediatric patients. Read the related article in . Visit NPub.org/Podcast for associated...
Dr. Tesha Monteith talks with Drs. Hayrunnisa Bolay, KC Brennan, and Gianluca Coppola about the International Headache Conference that took place in September and clinical advances in headache medicine. Read more about the . Disclosures...
The November 2023 replay of past episodes showcases five interviews on topics in stroke. The episode begins with an interview with on prehospital telestroke vs paramedic scores to accurately identify stroke reperfusion candidates. The episode...
Dr. Stacey Clardy talks with Drs. Brian Stamm and Behnam Sabayan about the spectrum of clinical presentations, neuroimaging patterns, and the predictors of radiographic and clinical outcomes from diffusion-restricted splenial lesions. Read the...
Dr. Jeff Burns talks with Dr. Natalia Rost about the AAN's brain health initiative. Read the related article in . Visit for associated article links.
Dr. Jennifer Majersik talks with Samantha Cote about the relationship between lifetime hormone exposure and cerebral small vessel disease in postmenopausal women in the UK-Biobank. Read the related article in . Visit for associated article links.
Dr. Kait Nevel talks with Dr. Philipp Karschnia about the assessment on whether MTHFR polymorphisms affects the risk for leukoencephalopathy. Read the related article in . Visit NPub.org/Podcast for associated article links.
Dr. Jeff Ratliff talks with Dr. Gregg Day about the adaption of the STAM3P screening scores in clinical practice to minimize diagnosis delays and missed opportunities for treatment in patients with suspected rapidly progressive dementia. Read the...
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in . Visit...